CAPTRUST Financial Advisors
TXG icon

CAPTRUST Financial Advisors’s 10x Genomics TXG Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$878K Buy
41,349
+77
+0.2% +$1.54K ﹤0.01% 1688
2025
Q4 		$673K Buy
41,272
+5,034
+14% +$76K ﹤0.01% 1729
2025
Q3 		$424K Sell
36,238
-41
-0.1% -$535 ﹤0.01% 1928
2025
Q2 		$420K Buy
+36,279
New +$331K ﹤0.01% 1839
2024
Q1 		– Sell
-4,488
Closed -$251K – 2643
2023
Q4 		$251K Buy
+4,488
New +$195K ﹤0.01% 2228
2022
Q3 		– Sell
-232
Closed -$10K – 3922
2022
Q2 		$10K Sell
232
-1,404
-86% -$72.8K ﹤0.01% 3757
2022
Q1 		$124K Buy
1,636
+1,217
+290% +$106K ﹤0.01% 2107
2021
Q4 		$62K Sell
419
-150
-26% -$23K ﹤0.01% 2512
2021
Q3 		$83K Sell
569
-25
-4% -$4.29K ﹤0.01% 2223
2021
Q2 		$116K Sell
594
-41
-6% -$7.42K ﹤0.01% 1913
2021
Q1 		$115K Buy
635
+435
+218% +$75.1K ﹤0.01% 1856
2020
Q4 		$28K Hold
200
– – ﹤0.01% 2102
2020
Q3 		$25K Hold
200
– – ﹤0.01% 1886
2020
Q2 		$18K Buy
+200
New +$15.6K ﹤0.01% 1987

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors's TXG Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its 10x Genomics (TXG) stake by 0.19% in Q1 2026, buying an estimated $1.54K and bringing the position to 41,349 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

CAPTRUST Financial Advisors first reported a position in TXG in Q2 2020 and has held it in 14 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • CAPTRUST Financial Advisors held 41,349 shares of 10x Genomics worth $878K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 77 10x Genomics shares in Q1 2026, an estimated $1.54K.
  • 10x Genomics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #1688 holding.
  • CAPTRUST Financial Advisors first reported a position in 10x Genomics in Q2 2020 and has held it in 14 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.